JYSELECA®▼ (filgotinib) recommended by NICE for use in patients with Ulcerative Colitis (UC)
Galapagos Biotech LTD announces that the National Institute of Health and Clinical Excellence (NICE) has recommended the use of JYSELECA® (filgotinib) for the treatment of adults with moderately to severely active Ulcerative Colitis (UC) when other treatments have not been successful....